Advisory Board and Editors Molecular Biology
Emiliano Maiani
Emiliano Maiani earned his MS and PhD in Molecular and Cellular Biology at the University of Rome “Tor Vergata”, Rome, Italy. In 2013, he joined the Cell Stress and Survival laboratory headed by prof. Francesco Cecconi at the Danish Cancer Society Research Center (DCRC), Copenhagen, Denmark. At the end of 2017, he moved for a second postdoc at the Computational Biology Laboratory headed by Elena Papaleo at the DCRC, Copenhagen. In this period, he expanded his knowledge to computational and structural biology. His research is focused on cancer biology and in particular in autophagy and DNA damage response pathways.
Safarina G Malik
Safarina G. Malik is a Principal Investigator at the Genome Diversity and Disease Division of the Mochtar Riady Institute for Nanotechnology, Tangerang, Banten, Indonesia, since January 2022. From 2011 to 2021 she lead the Lifestyle Diseases Research Group at the Eijkman Institute for Molecular Biology, Jakarta, Indonesia. Her key research topics and expertise include genetic diversity, microbiome, mitochondrial genetics and dysfunction, medical genetics, lifestyle disease association, nutrigenetics-nutrigenomics, population genetics and evolution.
Corinne F Maurice
CIFAR Azrieli Global Scholar and Tier 2 Canada Research Chair in Gut Microbial Physiology in the Department of Microbiology and Immunology at McGill University. Board member of the Microbiome and Disease Tolerance Centre.
Research in our lab aims to address two major goals:
* Identify and characterize the metabolically active microbial members of the gut microbiota.
* Determine the role of bacteriophages as regulators of the active gut microbiota.
Ewa J. Mellerowicz
Professor in plant cell and molecular biology at the Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Umea Plant Science Center.
Laurent Metzinger
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Koji Mikami
Prof. Koji Mikami is Professor of Department of Food Resource Development in School of Food Industrial Sciences at Miyagi University, Japan. He is also President of the Japanese Society of Applied Phycology. Prof. Mikami received his PhD in Plant Science from Hokkaido University in 1990. His area of expertise focuses on the physiology and molecular biology of development and environmental stress response in seaweeds, and the biotechnology of seaweeds (gene transfer and genetic transformation, application of seaweed genes for land green plants).
David S. Milstone
Assistant Professor of Pathology, Brigham and Women's Hospital and Harvard Medical School.
Maria Miragaia
Auxiliary Researcher at Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Portugal. Recipient of the 2010 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Grant and of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases fellows Award.
Thimios A Mitsiadis
Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland since 2006. Research in the fields of stem cells, genetics, molecular and experimental biology related to orofacial developmental and regeneration processes.
DDS degree from the Dental Faculty of the Kapodistrion University of Athens (Greece), Master degree for Immunology, Genetics and Differentiation, and PhD in Developmental Biology from the University of Lyon (France). Postdoctoral studies at the University of Helsinki (Finland), Karolinksa Nobel Institute (Stockholm, Sweden) and Yale University (USA). Previously Professor at the Mediterranean University (Marseilles, France), Visiting Professor at the Ecole Normale Superieure of Lyon (France), Clinical Senior Lecturer at King's College London (UK), Visiting Professor at the Polytechnic University of Marche (Ancona, Italy), Visiting Professor at the Second University of Napoli (Napoli, Italy). Chief-Editor of the “Frontiers of Craniofacial Biology and Dental Research”, Associate Editor of “Stem Cell Research”, Scientific Editor of “European Cells & Materials”, and part of the editorial board in additional 8 scientific journals. More than 110 original articles in journals such as “Journal of Cell Biology”, “Development”, “Developmental Biology”, “Nature Genetics”, “Science Signaling”, “Scientific Reports”, “Frontiers in Physiology” and more than 200 keynote and invited lectures.
Katherine Mitsouras
Katherine received her Bachelor's degree in Biochemistry and Molecular Biology from Brown University and her PhD in Biological Chemistry from the Geffen School of Medicine at UCLA. She subsequently trained in microarray technology development at Dr Stan Nelson's lab in the Department of Human Genetics at UCLA and collaborated with Agilent Technologies to develop microarrays to detect tissue-specific alternative splicing events in humans. Since 2007 she has been an Assistant, then Associate Professor of Biochemistry at Western University of Health Sciences.
Edward Mocarski
Professor Emeritus, Stanford University (2006) and Emory University (2021). Formerly, Robert W. Woodruff Professor of Microbiology and Immunology in the Emory Vaccine Center at Emory University (2006-2021) and Professor and Chair of Microbiology & Immunology at Stanford University (1983 - 2006). Previously (2009 and 2010), Distinguished Fellow at MedImmune, LLC, a wholly owned subsidiary of AstraZeneca.
Ipsita Mohanty
Dr. Ipsita Mohanty is a Research Associate II at the Children's Hospital of Philadelphia Research Institute
Her current research focuses on investigating the molecular mechanisms of nitric oxide signaling pathway at the proteome levels using multipronged approach of mouse genetics, ex vivo mechanistic functional study as well as high throughput mass spectroscopy techniques.
Dr. Mohanty has expertise in pharmacology, physiology, and proteomics with emphasis in intracellular signal transduction and GPCR signaling directed towards designing therapeutic strategies for cardiovascular disorders. Technical cognizance encompasses fields of Smooth Muscle pharmacology, Integrative Physiology, Contraction Physiology, Proteomics, Biochemistry, Molecular Biology, Bioinformatic Data Analysis (and related softwares) for Mass Spectrometry data and In-Vivo skills.